semaglutide for heart failure disease: may reduce risk by up to 20% in 6 months Weight loss injections can reduce

ZP CON BS 25FEB2026 Zepbound, its delivery device base and KwikPen are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates

This teamwork allows both providers to make informed decisions that protect your vision while optimizing your metabolic health

For patients first prescribed an ADM in September 2025, 72.5% filled a GLP-1 RA within 60 days

Common FDA-approved GLP-1 medications used for weight management include Wegovy, available as both an injectable and oral pill, Ozempic, Zepbound, and Mounjaro

Its not a magic solution, but it can help people stick to a healthy diet and reduce calorie intake over time